{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:54:52Z","timestamp":1770206092419,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K15471"],"award-info":[{"award-number":["18K15471"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.parkreldis.2020.12.017","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T21:42:55Z","timestamp":1610574175000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease"],"prefix":"10.1016","volume":"83","author":[{"given":"Takayasu","family":"Mishima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Houzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Eriguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3289-3555","authenticated-orcid":false,"given":"Hideo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.parkreldis.2020.12.017_bib1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","article-title":"Establishing diagnostic criteria for Perry syndrome","volume":"89","author":"Mishima","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2020.12.017_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.parkreldis.2020.06.006","article-title":"Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome","volume":"77","author":"\u010cierny","year":"2020","journal-title":"Park. Relat. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2020.12.017_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.parkreldis.2010.07.001","article-title":"Autonomic failures in Perry syndrome with DCTN1 mutation","volume":"16","author":"Ohshima","year":"2010","journal-title":"Park. Relat. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2020.12.017_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/mds.25833","article-title":"A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy","volume":"29","author":"Araki","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.12.017_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2016.06.007","article-title":"Cytoplasmic aggregates of dynactin in iPSC-derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome","volume":"30","author":"Mishima","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.12.017_bib6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.parkreldis.2015.09.037","article-title":"Impulse control disorders and punding in Perry syndrome","volume":"21","author":"Mishima","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.12.017_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jnen\/nlx049","article-title":"Perry Syndrome: a distinctive type of TDP-43 proteinopathy","volume":"76","author":"Mishima","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2020.12.017_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2018.02.038","article-title":"DCTN1 F52L mutation case of Perry syndrome with progressive supranuclear palsy-like tauopathy","volume":"51","author":"Honda","year":"2018","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.12.017_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Park. Relat. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.12.017_bib10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.12.017_bib11","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/mds.23338","article-title":"Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy","volume":"25","author":"Nagayama","year":"2010","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.12.017_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/practneurol-2020-002505","article-title":"DCTN1-related Parkinson-plus disorder (Perry syndrome)","volume":"20","author":"Richardson","year":"2020","journal-title":"Practical Neurol."},{"key":"10.1016\/j.parkreldis.2020.12.017_bib13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12350-014-9916-2","article-title":"Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations","volume":"21","author":"Nakajima","year":"2014","journal-title":"J. Nucl. Cardiol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:20:45Z","timestamp":1761178845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":13,"alternative-id":["S1353802021000080"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.12.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}